Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | HTR3A | P46098 | 4/20 | 0.37 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10153413 | 0.68 | KDM4E (0.40) | PARP1KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL2262299 | 0.67 | PARP1 (0.59) | PARP1KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL9738221 | 0.65 | PARP1 (0.45) | PARP1KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL6625361 | 0.65 | PARP1 (0.53) | PARP1KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL22270048 | 0.64 | HTR1A (0.39) | PARP1KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL13557120 | 0.63 | PARP1 (0.55) | PARP1KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL6200483 | 0.63 | PARP1 (1.00) | PARP1 | |
| SCHEMBL31635833 | 0.63 | PARP1 (0.34) | PARP1KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL11497603 | 0.62 | PARP1 (0.43) | PARP1KDM4EMEN1ALDH1A1GLA | |
| SCHEMBL10153352 | 0.61 | MAPT (0.33) | MAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8421066-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2013-04-16 | — | — | US | disclosed |
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-8174002-B2 | Organic electroluminescence device | FUJIFILM CORPORATION (JP) | 2012-05-08 | — | — | US | disclosed |
| US-20100051928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100051928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, CHRM1, LEF1 | PARP1 800/4885KDM4E 2229/4885MEN1 200/4885 |
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, CHRM1, LEF1 | PARP1 800/4885KDM4E 2229/4885MEN1 200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.